Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy

Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy

Item
http://www.wikidata.org/entity/Q36024915
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infectionsDoes prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.Pharmacokinetic/pharmacodynamic profiling of imipenem in patients admitted to an intensive care unit in India: A nonrandomized, cross-sectional, analytical, open-labeled study.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceContinuous versus intermittent administration of piperacillin-tazobactam in intensive care unit patients with ventilator-associated pneumoniaVariability in plasma concentration of cefotaxime in critically ill patients in an Intensive Care Unit of India and its pharmacodynamic outcome: A nonrandomized, prospective, open-label, analytical studyPharmacodynamic optimization of beta-lactams in the patient care setting.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Intraosseous and intravenous administration of antibiotics yields comparable plasma concentrations during experimental septic shock.Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Comparison of continuous infusion with intermittent bolus administration of cefotaxime on blood and cavity fluid drug concentrations in neonatal foals.Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
P2860

Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy

Item
http://www.wikidata.org/entity/Q36024915
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@ast
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@en
type
label
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@ast
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@en
prefLabel
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@ast
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Continuous vs. intermittent ce ...... tibility and clinical efficacy
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.2006.02730.X
P407
P433
P478
P577
P5875
P698
P921
P932